State Street SPDR S&P Biotech ETF XBI
Set alert
As of Nov 3, 10:59 AM ET
- YTD
- +27.93%
- 1 year
- +41.99%
- Open
- 152.96
- Prev close
- 152.05
- Mkt cap
- 7.95B
- Vol
- 2.06M
- Avg vol
- 8.95M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 152.83
- High
- 156.92
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 156.60
- 200-d avg
- 141.64
- 1y target
- 0.00
5D chart
Signals (125)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 10:10 AM | 49 minutes ago |
| RSI: Overbought | Nov 3, 9:35 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:30 AM | 1 hour ago |
| MACD: Buy Signal | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 3:55 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 3:45 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 3:40 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:30 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 2:40 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:25 PM | 20 hours ago |
Newest 20 of 125.
News
20 hours ago 247wallst.com
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
Tempus AI (NASDAQ:TEM | TEM Price Prediction) was trading higher this afternoon. It sat at $80.31, up 11.21% after the precision medicine company reported third-quarter results before the open.
4 days ago 247wallst.com
Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
Regeneron (NASDAQ:REGN | REGN Price Prediction) shares rose 13.55% in Friday's session, trading at $929.69 as of 9:45 AM ET on Oct 30, 2026. For a biotech worth roughly $94.
5 days ago zacks.com
ETFs That You May Consider Amid a Strengthening Biotech Outlook
Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.
1 month ago benzinga.com
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
Nasdaq 100 gains as softer PCE inflation cools Fed rate-hike bets, with oil above $91 and Micron earnings due after the bell Wednesday.
1 month ago benzinga.com
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
1 month ago benzinga.com
Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much
Over six years, U.S. nominal GDP rose 63% while the 30-year Treasury fell 60%. Are investors positioned for a surge in stocks and yields?
1 month ago benzinga.com
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
1 month ago benzinga.com
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back
JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.
2 months ago benzinga.com
What's Going On With Novavax Stock?
Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as traders weigh updated autumn vaccine authorizations against the company's broader strategic pivot…
2 months ago benzinga.com
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.
2 months ago benzinga.com
Novavax Stock Climbs Monday: What's Going On?
Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine approvals and broader biotech strength.
2 months ago benzinga.com
QUICK SPARK: $3.8B SPY Exodus Meets $3.7B QQQ Inflow in One Day
QQQ attracted $3.67 billion in ETF inflows while SPY saw $3.82 billion in outflows, as semiconductor ETFs also drew strong investor demand.
2 months ago benzinga.com
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
MRK, MRNA's cancer vaccine breakthrough could revive the mRNA trade, putting biotech and genomics ETFs back in focus.
2 months ago benzinga.com
Novavax Stock Moves Higher Wednesday: What's Driving the Action?
Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers.
2 months ago benzinga.com
‘Never Happened in History,’ Ex-Bridgewater Exec Warns AI Market Is Priced to Perfection
Former Bridgewater exec Bob Elliott warns the AI stock rally is an "expectations mania" built on unrealistic growth assumptions.
3 months ago benzinga.com
Here's How Much $100 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth Today
State Street SPDR S&P Biotech ETF (NYSE:XBI) has outperformed the market over the past 20 years by 3.16% on an annualized basis producing an average annual return of 12.55%. Currently, State Street…
4 months ago benzinga.com
Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF
Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.
5 months ago benzinga.com
Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data
Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
5 months ago benzinga.com
Taiwan Semiconductor, Freeport-McMoRan And More On CNBC's 'Final Trades'
Stephen Weiss chose Taiwan Semiconductor as final trade, citing partnership with Applied Materials. Other picks? Freeport-McMoRan.
6 months ago benzinga.com
Moderna's Legal Hit Steals Spotlight From Strong Sales
MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.
6 months ago benzinga.com
Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday?
U.S. stocks were mixed at midday Wednesday as tech stocks rallied while industrials dragged the Dow lower. Oil held above $90 and yields ticked higher, reflecting lingering geopolitical risk.
6 months ago benzinga.com
Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades'
Experts predict higher stock prices for CBRE Group and Morgan Stanley, while State Street SPDR S&P Biotech ETF and Citigroup are recommended.
7 months ago benzinga.com
Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.
-
7 months ago benzinga.com
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today
7 months ago benzinga.com
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes
Ahead of April, also the autism acceptance month, Defiance filed for a biopharma ETF with a pledge to donate profits to autism services and research.
7 months ago benzinga.com
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress
BridgeBio Pharma shares Phase 3 trial update, but early data show progress for rare muscle disease treatment.
8 months ago benzinga.com
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars
Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.
8 months ago benzinga.com
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
PTC Therapeutics, Inc. (PTCT) stock closed lower following the withdrawal of its New Drug Application for Translarna by the FDA.
8 months ago benzinga.com
Moderna, Mexico Partner To Boost Local Vaccine Production
Moderna signs a long-term deal with Mexico to build local mRNA production, transfer technology, and supply up to 10 million COVID vaccine doses for the 2025–2026 campaign.
9 months ago benzinga.com
Novavax Stock Is Surging Monday: What's Driving The Action?
Novavax shares are up on Monday following a licensing agreement with Pfizer for the use of its Matrix-M adjuvant.
9 months ago benzinga.com
Moderna (MRNA) Stock Pulls Back After Recent Strength
Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.
9 months ago benzinga.com
Why Your Pneumonia Shot Is About To Get A Massive Upgrade
Vaxcyte shares rise after starting Phase 3 trials for its VAX-31 pneumonia vaccine, expanding studies in adults and infants while planning major U.S. manufacturing investments.
9 months ago benzinga.com
Moderna Stock Explodes To New 52-Week High: What's Driving The Action?
Moderna Inc (NASDAQ: MRNA) stock is trading higher Thursday morning, hitting a new 52-week high after new cancer trial data.
10 months ago benzinga.com
Equities Surge, Commodities Sink As ETF Investors Streamline Portfolio For 2026
ETF flows show investors piling into equity ETFs while pulling money from commodities, leverage and macro trades as they streamline portfolios for 2026.
10 months ago benzinga.com
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight
Health care ETFs are positioned to benefit this year from weight-loss drug growth and defensive appeal as investors rotate away from AI stocks.
-
10 months ago benzinga.com
The Year-End 2025 Biotech Rally And What It Means For 2026
The Year-End 2025 Biotech Rally And What It Means For 2026
10 months ago benzinga.com
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026
KKR's 2026 Outlook finds value beyond the S&P 500. Explore investment strategies in Asia, biotech, and critical infrastructure.
-
10 months ago benzinga.com
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today
10 months ago benzinga.com
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Novo Nordisk's FDA-approved weight-loss pill intensifies its rivalry with Eli Lilly, putting health care and biotech ETFs in focus.
10 months ago benzinga.com
Why Is Trinity Biotech Stock Soaring Tuesday?
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.
10 months ago benzinga.com
Uber, Toast And More On CNBC's 'Final Trades'
Toast shares rose 2.9% to close at $37.28 on Monday while Uber gained 2.5% to settle at $81.26 during the session.
11 months ago benzinga.com
Eaton, FTAI Aviation And More On CNBC's 'Final Trades'
FTAI Aviation (NASDAQ: FTAI) is recommended by investment experts to diversify portfolios beyond tech, while Eaton (NYSE: ETN) and SPDR S&P Biotech ETF (NYSE: XBI) show promising price action. SoFi's…
11 months ago benzinga.com
Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades'
Apple will roll out three new iPhone models and is just pennies away from an all-time high. It's expected to have a solid quarter.
-
11 months ago benzinga.com
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off
Rotating To Healthcare
11 months ago benzinga.com
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades'
Stephen Weiss of Short Hills Capital Partners, named Taiwan Semiconductor Manufacturing Company as his final trade.
1 year ago benzinga.com
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?
Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025.
1 year ago benzinga.com
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin
As markets enter their strongest stretch, ETFs tied to AI, banking, and healthcare could shine. Here's where investors are finding fresh momentum.
1 year ago benzinga.com
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.
1 year ago benzinga.com
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures.
1 year ago benzinga.com
4 Biotech Stocks Seeing Explosive Momentum Gains
The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's a look at several momentum standouts in the biotech space that appear to…